Potential adverse effects of proton pump inhibitors

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Gastroenterology Reports

• Publication date

  2008-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11894-008-0045-4PMID 18625128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Very Long (up to 10 Years) Proton Pump Blockade on Human Gastric Mucosa

  2009cited by this paper
• Proton pump inhibitor therapy and hip fracture risk.

  2007cited by this paper
• Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

  2007cited by this paper
• Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression

  2007cited by this paper
• Chronic proton pump inhibitor therapy and the risk of colorectal cancer.

  2007cited by this paper
• Systematic review: proton pump inhibitor‐associated acute interstitial nephritis

  2007cited by this paper
• Are Proton‐Pump Inhibitors (PPIs) Associated with an Increased Risk of Community‐Acquired Pneumonia (CAP)? A Nested Case‐Control Study Investigating Recent PPI Exposure and CAP: 892

  2007cited by this paper
• Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.

  2007cited by this paper
• Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro‐oesophageal reflux disease associated with a formulary change at a VA medical center

  2007cited by this paper
• Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

  2007cited by this paper
• Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community-Acquired Pneumonia in Children

  2006cited by this paper
• The Burden of Gastrointestinal and Liver Diseases, 2006

  2006cited by this paper
• Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture

  2006cited by this paper
• Calcium absorption and achlorhydria.

  2006cited by this paper
• Proton pump inhibitors and gastric neoplasia

  2006cited by this paper
• Long-term proton pump inhibitor therapy and risk of hip fracture.

  2006cited by this paper
• Proton pump inhibitors and acute interstitial nephritis.

  2006cited by this paper
• Proton pump inhibitors reduce gallbladder function

  2006cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.

  2005cited by this paper
• Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

  2004cited by this paper
• Mislocalisation of hephaestin, a multicopper ferroxidase involved in basolateral intestinal iron transport, in the sex linked anaemia mouse

  2004cited by this paper
• A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.

  2004cited by this paper
• Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies

  2004cited by this paper
• A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?

  2004cited by this paper
• Increased Vitamin B12 Requirement Associated with Chronic Acid Suppression Therapy

  2003cited by this paper
• GI SNAPSHOT

  2003cited by this paper
• Gastric acid‐suppressive therapy and community‐acquired respiratory infections

  2003cited by this paper
• Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.

  2002cited by this paper
• Short-Term Omeprazole Treatment Does Not Influence Biochemical Parameters of Bone Turnover in Children

  2002cited by this paper
• Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.

  2001cited by this paper
• Vitamin B12 levels during prolonged treatment with proton pump inhibitors.

  2000cited by this paper
• Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

  2000cited by this paper
• Gastric acid suppression does not promote clostridial diarrhoea in the elderly.

  2000cited by this paper
• Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors

  2000cited by this paper
• Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis

  1999cited by this paper
• Iron absorption in patients with Zollinger–Ellison syndrome treated with long‐term gastric acid antisecretory therapy

  1998cited by this paper
• Gastrin and colorectal cancer: a prospective study.

  1998cited by this paper
• Effect of L-lactic acid on calcium absorption in rats fed omeprazole.

  1998cited by this paper
• The General Practice Research Database: quality of morbidity data.

  1997cited by this paper
• Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.

  1996cited by this paper
• Effect of short‐ and long‐term treatment with omeprazole on the absorption and serum levels of cobalamin

  1996cited by this paper
• Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.

  1993cited by this paper
• Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans

  1993cited by this paper
• Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy

  1992cited by this paper
• Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment.

  1992cited by this paper
• Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.

  1991cited by this paper
• Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

  1986cited by this paper
• Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation

  1986cited by this paper
• Calcium absorption and achlorhydria.

  1985cited by this paper
• An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.

  1984cited by this paper
• Effect of sulfated and non-sulfated gastrin and octapeptide-cholecystokinin on cat gall bladder in vitro

  1976cited by this paper
• The Environment and Disease: Association or Causation?

  1965cited by this paper

• Feeding Difficulties, Eating Disorders and Therapeutic Approaches in Autism Spectrum Disorder: An Overview.

  2025cites this paper
• THE FEATURES OF ENDOVASCULAR SURGERY FOR DUODENAL ULCER BLEEDING

  2023cites this paper
• Metabolic Profiling of Heliotropium crispum Aerial Parts Using HPLC and FTIR and In Vivo Evaluation of Its Anti-Ulcer Activity Using an Ethanol Induced Acute Gastric Ulcer Model

  2022cites this paper
• Pertinence Des Prescriptions D'inhibiteurs De La Pompe À Protons Chez Les Patients Admis À L'hopital : Une Etude Observationnelle.

  2022cites this paper
• Gastroprotective effect of low dose Eugenol in experimental rats against ethanol induced toxicity: Involvement of antiinflammatory and antioxidant mechanism.

  2022cites this paper
• Polypharmacy is associated with malnutrition and activities of daily living disability among daycare facility users

  2021cites this paper
• Prescription drug survey of elderly patients with degenerative musculoskeletal disorders

  2021cites this paper
• Proton Pump Inhibitor-Induced Galactorrhea in a Kidney Transplant Recipient: A Friend or Foe?

  2020cites this paper
• Gastroösophageale Refluxkrankheit

  2019cites this paper
• Efficacy of Jianpi Liqi therapy for functional dyspepsia

  2019cites this paper
• Optimizing medication management for patients with cirrhosis: Evidence‐based strategies and their outcomes

  2018cites this paper
• Comparative Study of Spontaneous Bacterial Peritonitis in Cirrhosis Patients Managed with and without Proton Pump Inhibitors

  2018influential citation
• Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial

  2017cites this paper
• Potential Adverse Effects of Proton Pump lnhibitors in the Elderly

  2017cites this paper
• Repeat-measures longitudinal study evaluating behavioural and gastrointestinal symptoms in children with autism before, during and after visceral osteopathic technique (VOT).

  2016cites this paper
• The effect of Flos Lonicerae Japonicae extract on gastro-intestinal motility function.

  2016cites this paper
• The use of PPI is associated with spontaneous bacterial peritonitis in cirrhotic patients of different ethnic groups : a meta-analysis

  2016cites this paper
• Routine prophylaxis with proton pump inhibitors and post‐transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal

  2016cites this paper
• Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis

  2015cites this paper
• Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database*

  2015cites this paper
• Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.

  2015cites this paper
• Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract

  2015cites this paper
• The Selection and Use of Essential Medicines.

  2015cites this paper
• Proton pump inhibitor prescription in patients with liver cirrhosis: indications in theory and the real world

  2015cites this paper
• Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito

  2014cites this paper
• Impact of Chronic Use of Proton Pump Inhibitor Drugs on Vitamin B 12 Status , and the Role of Fortified Foods

  2014cites this paper
• Pantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in rats

  2014cites this paper
• A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study

  2014cites this paper
• NHG Standaard Maagklachten (tweede herziening)

  2013cites this paper
• Prevalence and determinants of gastrointestinal symptoms in the Dutch community

  2013cites this paper
• Langzeitergebnisse subjektiver Patientenzufriedenheit bei laparoskopischer Fundoplicatio nach Nissen-Rosetti und Toupet

  2013cites this paper
• Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application

  2013cites this paper
• Reflux and aerodigestive tract diseases

  2013cites this paper
• Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.

  2013cites this paper
• Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development.

  2013cites this paper
• Minimally invasive techniques in foregut surgery.

  2013cites this paper
• Using syndromic surveillance to estimate baseline rates for healthcare-associated infections in critical care units of small animal referral hospitals.

  2013cites this paper
• Stress prophylaxis in intensive care unit patients and the role of enteral nutrition.

  2012cites this paper
• Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan

  2012cites this paper
• Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice

  2012cites this paper
• Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database

  2012cites this paper
• Reducing adverse effects of proton pump inhibitors.

  2012cites this paper
• Inflammatory Disorders of the Stomach

  2012cites this paper
• Medical Management of Gastroesophageal Reflux Disease

  2012cites this paper
• GERD: Langzeitnebenwirkungen einer lebenslangen Einnahme von Protonenpumpenhemmern

  2011cites this paper
• Message from GAPNA’s President: Strategic Plan for the Future and Addressing the Changes Affecting the GNP Certification

  2011cites this paper
• IS AGE A CONTRAINDICATION FOR LAPOROSCOPIC ANTI-REFLUX SURGERY IN ELDERLY

  2011cites this paper
• Treatment of gastroesophageal reflux disease: a call for increase awareness and local research.

  2011cites this paper
• Laparoscopic Antireflux Surgery After Failed Endoscopic Treatments for Gastroesophageal Reflux Disease

  2011cites this paper
• Nosocomial infection rates in veterinary referral hospitals: Using syndromic surveillance to establish baseline rates

  2011cites this paper
• Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

  2011cites this paper
• Review of proton pump inhibitors for the initial treatment of heartburn: Is there a dose ceiling effect?

  2011cites this paper
• Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice.

  2011cites this paper
• Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients – a systematic review and meta‐analysis

  2011cites this paper
• Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and Magnesium

  2010cites this paper
• Long term use of proton pump inhibitors : is there an increase in fracture risk?

  2010cites this paper
• INTERNATIONAL HEALTH NEWS

  2010cites this paper
• PGI35 PROTON PUMP INHIBITOR USE IN SENIORS: AN ANALYSIS FOCUSING ON DRUG CLAIMS 2001 TO 2008

  2010cites this paper
• Gastroprotective effect of rutin against indomethacin-induced ulcers in rats.

  2010cites this paper
• Role of the primary care provider in the diagnosis and management of heartburn

  2010cites this paper
• Gastroprotezione con inibitori di pompa protonica in ospedale: oltre all’(ab)uso, anche eventi avversi?

  2010influential citation
• Editorial: Just How “Difficult” Is It to Withdraw PPI Treatment?

  2010cites this paper
• pump inhibitors : adverse effects beyond ( over ) utilization ?

  2010influential citation
• Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.

  2009cites this paper
• Corpus predominant gastritis: what does it mean?

  2009cites this paper
• Hospitalizations because of Adverse Drug Reactions in Elderly Patients Admitted through the Emergency Department

  2009cites this paper
• Will skepticism stop the evolution of endoscopic GERD treatment?

  2009cites this paper
• The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis

  2009cites this paper
• Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.

  2009cites this paper
• Importance of gastrin in the pathogenesis and treatment of gastric tumors.

  2009cites this paper
• The selection and use of essential medicines.

  2008cites this paper
• Iranian Journal of Basic Medical Sciences Pantoprazole, a Proton Pump Inhibitor, Increases Orthodontic Tooth Movement in Rats

  year unknowncites this paper